Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin to Reduce Airway Glucose in COPD Patients

NCT03651895 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT03651895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03651895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin to Reduce Airway Glucose in COPD Patients
Lead sponsor
Imperial College London
Phase
Phase 2
Overall status
Completed
Start date
May 17, 2022
Completion date
June 1, 2023
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease